Menu Back to 6th-Latin-American-Regulatory-Conference-LARC-2014

Program Committee

  • Justina  Molzon
    Justina Molzon FDA (Retired), United States
  • Mike  Ward
    Mike Ward Manager, International Programs Division Health Canada, Canada
  • Sergio  Guerrero, MD
    Sergio Guerrero, MD President/CEO Accelerium Clinical Research, Mexico
  • Ines  Bignone, MD
    Ines Bignone, MD Department of Medicine Evaluation ANMAT, Argentina
  • Guisela  Zurich Reszczynski
    Guisela Zurich Reszczynski Head ANAMED/ISPCH, Chile
  • Laura  Gomes Castanheira
    Laura Gomes Castanheira Head of Regulatory Affairs Hemobrás- Empresa Brasileira de Hemoderivados e Biotecnologia, Brazil
  • Beatriz  Luna
    Beatriz Luna Director, Medicines Department Ministry of Public Health, Uruguay
  • Cesar  Masache, MD
    Cesar Masache, MD Head, National System on Pharmacotherapy & Pharmacovigilance Ministry of Public Health, Ecuador
  • Gerardo  Méndez Ciancaglini, MD
    Gerardo Méndez Ciancaglini, MD Professor Universidad De Buenos Aires, Argentina
  • Lily  Gordillo, MSc
    Lily Gordillo, MSc Director, Pharmacovigilance Ministry of Public Health, Guatemala
  • João  Massud, MD
    João Massud, MD President Brazilian Society of Pharmaceutical Medicine (SBMF), Brazil
  • Jenny  Paredes, MD
    Jenny Paredes, MD Latin American Operations Manager PRA Health Sciences, Mexico
  • Maria Guazzaroni  Jacobs, PhD
    Maria Guazzaroni Jacobs, PhD Director, Quality and Regulatory Policy (QRP) Pfizer Inc., United States
  • Thomas  Kirchlechner, PhD
    Thomas Kirchlechner, PhD Head, Regulatory Emerging Markets Sandoz Biopharmaceuticals Development (Novartis), Austria
  • Rivelino  Flores, MSc
    Rivelino Flores, MSc Director, Regulatory Affairs & Innovation CANIFARMA, Mexico
  • Ian  Rentsch, JD
    Ian Rentsch, JD Senior Director, Business Development and Head of Latin American Sales Quintiles, Argentina
Load More